Venrock Healthcare Capital Partners II, L.P.'s Net Worth

$618 Million

Estimate Recalculated Feb 27, 2024 08:53PM EST

Who is Venrock Healthcare Capital Partners II, L.P.?

Venrock Healthcare Capital Partners II, L.P. has an estimated net worth of $618 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..

SEC CIK

Venrock Healthcare Capital Partners II, L.P.'s CIK is 0001602264

Past Insider Trading and Trends

2022 was Venrock Healthcare Capital Partners II, L.P.'s most active year for acquiring shares with 46 total transactions. Venrock Healthcare Capital Partners II, L.P.'s most active month to acquire stocks was the month of May. 2019 was Venrock Healthcare Capital Partners II, L.P.'s most active year for disposing of shares, totalling 4 transactions. Venrock Healthcare Capital Partners II, L.P.'s most active month to dispose stocks was the month of September. 2019 saw Venrock Healthcare Capital Partners II, L.P. paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 Venrock Healthcare Capital Partners II, L.P. cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.06%
400K
$34.50
$13,800,000.00
4.02M
Dec 13
Form 3
0
0
No matching records found

Shockwave Medical, Inc. (SWAV) Snapshot price: $236.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.12M
2.12M
Mar 11
Form 3
0
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.46%
-500.00K
$28.75
-$14,375,000.00
1.54M
Mar 18
Form 3
0
0
No matching records found

Altimmune, Inc. (ALT) Snapshot price: $10.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.22%
-1.00M
3.5M
Feb 25
Form 4
+50.00%
1.5M
$7.54
$11,310,000.00
4.5M
Jun 15
Form 4
+76.85%
1.3M
$8.74
$11,395,493.13
3M
May 26 - May 28
Form 3
0
0
No matching records found

Unum Therapeutics Inc. (COGT) Snapshot price: $6.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.55%
451K
$2.52
$1,137,120.00
4.36M
Aug 14 - Aug 18
Form 3
0
0
No matching records found